Jaguar Health (JAGX) Invested Capital (2014 - 2017)

Jaguar Health (JAGX) has reported Invested Capital for 4 consecutive years, with $1.6 million the latest figure, recorded in Q4 2017.

• In Q4 2017, Invested Capital fell 16.17% year-over-year to $1.6 million; the TTM figure through Sep 2018 stood at $1.6 million (down 79.33% YoY), while the FY2017 annual figure was $1.6 million, down 16.17% from the prior year.
• Invested Capital eased to $1.6 million in Q4 2017 per JAGX's latest filing, from $1.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $2.1 million in Q1 2016 and bottomed at $16581.0 in Q4 2014.
• Historically, Invested Capital has averaged $1.5 million across 4 years, with a median of $1.8 million in 2015.
• Annual changes were most pronounced in 2015 — Invested Capital soared 10200.34% — and 2017, when it fell 16.17%.
• Jaguar Health's Invested Capital stood at $16581.0 in 2014, then jumped by 10200.34% to $1.7 million in 2015, then rose by 12.4% to $1.9 million in 2016, then decreased by 16.17% to $1.6 million in 2017.
• Business Quant data shows JAGX's Invested Capital at $1.6 million in Q4 2017, $1.8 million in Q3 2017, and $2.1 million in Q2 2017.